Bone Tissue Engineering involves the method to generate new bone for skeletal use which helps the humans for bone transplantation. Some of these techniques patented are given below.
Patent no: 7,052,518 titled ‘Artificial bone and tissue engineering carrier’ with the abstract : An artificial bone comprising a calcium phosphate-based ceramic porous body having a plurality of pores which are three-dimensionally distributed throughout an entire region of the porous body including a surface thereof and have a diameter ranging from 0.01 .mu.m to 2000 .mu.m, and interconnecting portions which are formed between neighboring pores, interconnect a plurality of pores existing on a surface of the porous body.
Patent no: 6,767,928 titled Mineralization and biological modification of biomaterial surfaces with the abstract: Disclosed are advantageous methods for patterning and/or mineralizing biomaterial surfaces. The techniques described are particularly useful for generating three-dimensional or contoured bioimplant materials with patterned surfaces or patterned, mineralized surfaces. Also provided are various methods of using the mineralized and/or patterned biomaterials in tissue engineering, such as bone tissue engineering, providing more control over ongoing biological processes, such as mineralization, growth factor release, cellular attachment and tissue growth.
Patent no: 6,541,022 titled ‘Mineral and cellular patterning on biomaterial surfaces’ with the abstract : Disclosed are advantageous methods for patterning and/or mineralizing biomaterial surfaces. The techniques described are particularly useful for generating three-dimensional or contoured bioimplant materials with patterned surfaces or patterned, mineralized surfaces. Also provided are various methods of using the mineralized and/or patterned biomaterials in tissue engineering, such as bone tissue engineering, providing more control over ongoing biological processes, such as mineralization, growth factor release, cellular attachment and tissue growth.
Patent no: 6,228,117 titled ‘Device for tissue engineering bone’ with the abstract : A device for bone tissue engineering is described which comprises a scaffold material consisting of a bioactive, osteoconductive and bone-bonding segmented thermoplastic copolyester and cultured osteogenic or osteoprogenitor cells, especially bone cells. The copolyester consists essentially of a multiplicity of recurring long-chain ester units and short-chain ester units, the long-chain ester units comprising from 35 to 80% by weight of the copolyester and being represented by the formula and the short-chain ester units being represented by the formula wherein L is a divalent group remaining after removal of terminal hydroxyl groups from a poly(oxyalkylene) glycol with an average molecular weight of between 300 and 3000; R is a divalent group remaining after removal of carboxyl groups from a dicarboxylic acid having a molecular weight of less than 300; Q is an alkylene group having 1-6 carbon atoms and/or a cyclohexylene of phenylene group; and E is an alkylene group having 2-6 carbon atoms.
Patent no: 6,165,486 titled Bio-compatible compositions and methods of using same with the abstract: Blends of biodegradable polymers, preferably poly(caprolactone) and poly(D,L-lactic-co-glycolic) acid are discussed as well as their applications in the medical field, particularly with regard to bone tissue engineering. Preferably, hydroxyapatite ("HA") granules are incorporated into the blends and the resulting blends have desirable mechanical, physical, and biological characteristics. Even more preferably the compositions of the present invention are utilized to form osteoconductive composites that supported bone cell growth on the surface as well as throughout the scaffold.